Genetics, Genome Project and Pharma Companies

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

JANUARY 24, 2023

Drug development has long been an issue for the pharma industry, due to the expense and the high failure rate of potential treatments. Ben Hargreaves finds that the vast amount of genetic data that exists today could help provide a faster, more targeted way of developing new drug candidates.

Genetics

Genetics Drugs Genome Project Biobanking

Unlocking disease treatment with large-scale research

pharmaphorum

DECEMBER 6, 2022

A few decades ago, gathering genetic data on the scale of the 100,000 Genomes Project would have been unthinkable – it was only in 2003 that the entire human genome was mapped. However, the scale goes far beyond 100,000 genomes and instead is looking to recruit five million adult volunteers. Aims for the project.

Genome Project

Genome Project Research Genome Genomics

Clinical Research Informer

Can genetic data be a magic bullet for drug R&D?

Unlocking disease treatment with large-scale research

Webinars

Stay Connected